Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...
Intellihot, an innovative designer/manufacturer of built-environment systems that challenge legacy approaches for sustainability, recently released telliSize, a six-dimension dynamic simulation software tool for correctly...
3D Systems and SWANY Co., Ltd. announced a collaboration intended to promote the adoption of large-format pellet extrusion 3D printing in Japan. Through this collaboration, SWANY...
